Paracelsus Pharma Projects SPRL
The score of Paracelsus Pharma Projects shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -15 % Total assets -22 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Paracelsus Pharma Projects's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −10,092 € | ||||
| Equity | 107,010 € | ||||
| Cash | 1,284 € | ||||
| EBITDA | 7,589 € | ||||
| Total assets | 197,179 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jul 2026
- Year ended 31 Dec 2024filed on 13 Jun 2025
- Year ended 31 Dec 2023filed on 30 Jul 2024
- Year ended 31 Dec 2022filed on 20 Jun 2023
- Year ended 31 Dec 2021filed on 06 Jul 2022
Paracelsus Pharma Projects's financial analysis
- Solvency54.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Paracelsus Pharma Projects
Paracelsus Pharma Projects's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0475.409.569
- VAT number
- BE0475409569
- Peppol
- Registered · 0208:0475409569 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 01 Aug 2001
- Registered office
- 9880 Aalter
- Latest accounts
- 2025 · filed on 29 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Paracelsus Pharma Projects (SPRL) has been based in Aalter since 2001, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 10,092 € and equity of 107,010 €; its revenue is not published. Its solvency stands at 54.3%, above the median of its sector (44.2%).
Companies similar to Paracelsus Pharma Projects
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de la Molignée Retail sale of pharmaceutical products Mettet · balance sheet 198,726 €
- Apotheek Bellens Retail sale of pharmaceutical products Lokeren · balance sheet 195,155 €
- AC Bizet Retail sale of pharmaceutical products Anderlecht · balance sheet 199,908 €
- Heyde Pharma Retail sale of pharmaceutical products Jabbeke · balance sheet 192,810 €
- Bopre Retail sale of pharmaceutical products Aalst · balance sheet 196,068 €
- Panadem Retail sale of pharmaceutical products Woluwe-Saint-Pierre · balance sheet 188,078 €
- Medisame Retail sale of pharmaceutical products Stabroek · balance sheet 184,789 €
- Apopark Retail sale of pharmaceutical products Leuven · balance sheet 210,821 €
Frequently asked questions about Paracelsus Pharma Projects
What is the revenue of Paracelsus Pharma Projects?
Paracelsus Pharma Projects files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Paracelsus Pharma Projects?
In Belgium, the VAT number is the company number prefixed with BE: BE0475409569 for Paracelsus Pharma Projects, if the company is VAT-registered. Its company number (CBE) is 0475.409.569.
Where is the registered office of Paracelsus Pharma Projects?
According to the CBE register, the registered office of Paracelsus Pharma Projects is in 9880 Aalter.
What is the equity of Paracelsus Pharma Projects?
At the close of the 2025 financial year, the equity of Paracelsus Pharma Projects amounts to 107,010 €, a solvency of 54.3% of total assets.
Who manages Paracelsus Pharma Projects?
The register lists 1 active mandates at Paracelsus Pharma Projects. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Paracelsus Pharma Projects
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →